Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Open in Screener

AZO

Autozone Inc

Dec 12 • 04:00PM ET

3,445.71

-23.39 -0.67 %

Consumer Cyclical • Auto Parts • USA • NYSE

Peers: ORLY AAP GPC AN LAD PAG KMX SAH ABG CASY

| Held by: VTI VOO VUG SPY VO IVV XLY VOT USMV RSP

Index	S&P 500	P/E	24.03	EPS (ttm)	143.41	Insider Own	0.26%	Shs Outstand	16.63M	Perf Week	-9.86%
Market Cap	57.31B	Forward P/E	19.35	EPS next Y	178.03	Insider Trans	-17.84%	Shs Float	16.59M	Perf Month	-9.05%
Enterprise Value	68.79B	PEG	1.81	EPS next Q	27.87	Inst Own	94.26%	Short Float	1.81%	Perf Quarter	-18.60%
Income	2.46B	P/S	2.97	EPS this Y	4.09%	Inst Trans	-1.70%	Short Ratio	2.14	Perf Half Y	-5.41%
Sales	19.29B	P/B	-	EPS next Y	18.07%	ROA	13.27%	Short Interest	0.30M	Perf YTD	7.61%
Book/sh	-194.67	P/C	199.25	EPS next 5Y	10.69%	ROE	-	52W High	4388.11 -21.48%	Perf Year	2.94%
Cash/sh	17.29	P/FCF	32.02	EPS past 3/5Y	7.32% 15.03%	ROIC	28.88%	52W Low	3162.00 8.97%	Perf 3Y	40.34%
Dividend Est.	-	EV/EBITDA	16.45	Sales past 3/5Y	5.23% 8.44%	Gross Margin	52.15%	Volatility	3.53% 2.28%	Perf 5Y	197.77%
Dividend TTM	-	EV/Sales	3.57	EPS Y/Y TTM	-4.26%	Oper. Margin	18.42%	ATR (14)	95.04	Perf 10Y	352.79%
Dividend Ex-Date	-	Quick Ratio	0.13	Sales Y/Y TTM	3.81%	Profit Margin	12.78%	RSI (14)	27.65	Recom	1.45
Dividend Gr. 3/5Y	- -	Current Ratio	0.86	EPS Q/Q	-4.56%	SMA20	-8.94%	Beta	0.41	Target Price	4428.61
Payout	0.00%	Debt/Eq	-	Sales Q/Q	8.15%	SMA50	-10.35%	Rel Volume	1.14	Prev Close	3469.10
Employees	130000	LT Debt/Eq	-	Earnings	Dec 09 BMO	SMA200	-9.98%	Avg Volume	140.89K	Price	3445.71
IPO	Apr 02, 1991	Option/Short	Yes / Yes	EPS/Sales Surpr.	-5.22% -0.23%	Trades		Volume	161,123	Change	-0.67%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-04-25	Initiated	Robert W. Baird	Outperform	$4500
Nov-13-25	Upgrade	Goldman	Neutral → Buy	$4262
Oct-31-25	Downgrade	Erste Group	Buy → Hold
Sep-18-25	Resumed	Wolfe Research	Outperform	$4741
May-21-25	Upgrade	BofA Securities	Neutral → Buy	$4800
May-02-25	Upgrade	Oppenheimer	Perform → Outperform	$4600
Apr-01-25	Upgrade	Goldman	Sell → Neutral	$3811
Mar-21-25	Upgrade	DA Davidson	Neutral → Buy	$3500 → $4192
Mar-05-25	Downgrade	Argus	Buy → Hold
Dec-13-24	Initiated	BMO Capital Markets	Outperform	$3700
Oct-14-24	Downgrade	Goldman	Buy → Sell	$3205 → $2917
Mar-19-24	Initiated	Mizuho	Buy	$3450
Dec-13-23	Resumed	William Blair	Outperform
Dec-06-23	Upgrade	Raymond James	Outperform → Strong Buy	$2850 → $3100
Oct-10-23	Initiated	TD Cowen	Outperform	$2975
Oct-06-23	Downgrade	Oppenheimer	Outperform → Perform	$2850 → $2600
Jun-28-23	Initiated	Northcoast	Neutral
Jun-16-23	Upgrade	UBS	Neutral → Buy	$2800 → $2900
Jun-12-23	Upgrade	Evercore ISI	In-line → Outperform	$2640 → $2700
Jun-01-23	Upgrade	BofA Securities	Underperform → Neutral	$2120 → $2465

Show Previous Ratings

Dec-13-25 07:45PM	Are AutoZone (AZO) Stock Investors Happy, or Did They Miss Out? (Motley Fool)
Dec-12-25 09:33AM	Earnings live: Broadcom stock falls despite upbeat outlook, Lululemon pops, Costco dips (Yahoo Finance)
Dec-11-25 04:49PM	Earnings live: Broadcom gives upbeat forecast for AI demand, Lululemon stock pops, Costco dips (Yahoo Finance)
08:48AM	AutoZone Q1 Earnings & Revenues Fall Short of Expectations (Zacks)
07:59AM	Earnings live: Oracle stock dives on AI bubble concerns. Broadcom results later today offer the next test. (Yahoo Finance)
07:59AM	Loading…
07:59AM	Earnings live: Oracle stock dives on AI bubble concerns. Broadcom results after the close offer the next test. (Yahoo Finance)
Dec-10-25 04:49PM	Earnings live: Oracle stock slides, Adobe edges higher, GameStop falls (Yahoo Finance)
01:06PM	AutoZone (AZO) Stock Trades Down, Here Is Why (StockStory)
09:53AM	Why AutoZone's Stock Drop Could Be a Golden Buying Opportunity (MarketBeat)
09:44AM	Why Shares of AutoZone Suddenly Plunged (Motley Fool)
09:22AM	Company News for Dec 10, 2025 (Zacks)
08:03AM	Earnings live: GameStop, Chewy stocks slide, with Oracle's closely watched results on deck (Yahoo Finance)
08:03AM	Earnings live: GameStop stock slides, Chewy seesaws, with Oracle's closely watched results on deck (Yahoo Finance)
08:03AM	Earnings live: GameStop stock slides, Chewy fluctuates, with Oracle's closely watched results on deck (Yahoo Finance)
02:57AM	Heard on the Street Tuesday Recap: It's Not Cheap to Run the Biggest Bank (The Wall Street Journal)
12:30AM	Loading…
12:30AM	AZO Q4 Deep Dive: Margin Pressures Persist as Store Expansion Accelerates (StockStory)
Dec-09-25 05:30PM	Heard on the Street Recap: It Isn't Cheap to Run the Biggest Bank (The Wall Street Journal) -7.17%
05:11PM	AutoZone opens 53 new stores while navigating inflation and tariff cost increases (Fox Business)
05:06PM	Stocks to Watch Tuesday Recap: Nvidia, AutoZone, PepsiCo, Campbells (The Wall Street Journal)
04:59PM	Earnings live: GameStop stock sinks, Cracker Barrel tumbles as sales decline (Yahoo Finance)
04:31PM	Stock Market Today: Dow Retreats As Nasdaq Pulls Ahead; JP Morgan, Nvidia On Losing End (Live Coverage) (Investor's Business Daily)
04:01PM	AutoZone Inc (AZO) Q1 2026 Earnings Call Highlights: Strong Sales Growth Amid LIFO Challenges (GuruFocus.com)
04:00PM	JPMorgan expects to spend $105B in 2026, Exxon lifts oil target (Yahoo Finance Video)
03:52PM	Stock Market Today: Dow Lags As Nasdaq Leads The Way; This Sports Equipment Name Breaks Out (Live Coverage) (Investor's Business Daily)
03:48PM	Analyst Report: AutoZone, Inc. (Morningstar Research)
03:05PM	Stocks to Watch Tuesday: Nvidia, AutoZone, PepsiCo, Campbells (The Wall Street Journal)
01:49PM	Stock Market Today: Dow Falls As JPMorgan Veers Lower; This Auto Parts Name Skids (Live Coverage) (Investor's Business Daily)
12:34PM	Why Advance Auto Parts Stock Slumped Today (Motley Fool)
12:25PM	This Car Stock Is the S&P 500s Worst Performer Today. Heres Why. (Barrons.com)
11:59AM	Stock Market Today: Dow Leads As Nasdaq Reverses Higher; This Food Stock Rallies On Surprise (Live Coverage) (Investor's Business Daily)
11:21AM	Loading…
11:21AM	Why AutoZone (AZO) Shares Are Getting Obliterated Today (StockStory)
10:47AM	Market Awaits JOLTS Report After the Bell (Zacks)
10:40AM	This Car Stock Is One of the S&P 500's Worst Performers Today. Here's Why. (Barrons.com)
10:29AM	AutoZone Profit Falls as Higher Costs Continue from Tariffs (The Wall Street Journal)
10:19AM	Pre-markets "Risk Off" Ahead of Wednesday's Fed Decision (Zacks)
09:56AM	Stock Market Today: Dow Up Ahead Of Fed Meeting; Nvidia Falls Despite Trump Comments (Live Coverage) (Investor's Business Daily)
09:30AM	Compared to Estimates, AutoZone (AZO) Q1 Earnings: A Look at Key Metrics (Zacks)
09:28AM	CVS lifts outlook, Home Depot remains cautious, AutoZone earnings (Yahoo Finance Video)
09:01AM	Stock Market Live December 9: Anticipating a Rate Cut, the S&P 500 (VOO) Rises a Bit (24/7 Wall St.)
08:37AM	Earnings live: AutoZone, Toll Brothers stocks fall, Campbell's sales decline (Yahoo Finance)
08:08AM	Stock Market Today: Dow Edges Higher Ahead Of Fed Meeting; Nvidia Rallies On Trump Comments (Live Coverage) (Investor's Business Daily)
08:05AM	AutoZone (AZO) Q1 Earnings and Revenues Miss Estimates (Zacks)
07:40AM	AutoZone falls as earnings miss estimates amid growth investments (Investing.com)
07:30AM	AutoZone's (NYSE:AZO) Q4 CY2025 Earnings Results: Revenue In Line With Expectations (StockStory)
07:02AM	AutoZone: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
06:55AM	AutoZone 1st Quarter Total Company Same Store Sales Increase 4.7%; Domestic Same Store Sales Increase 4.8%; 1st Quarter EPS of $31.04 (GlobeNewswire)
05:57AM	Can earnings revive Campbell's stock price? (MarketWatch)
04:18AM	Stock Market Today: Dow, S&P 500 and Nasdaq steady as Fed decision looms; job openings data on tap; Nvidia shares up after chips-to-China report (MarketWatch)
03:17AM	Fed Rate Decision, Broadcom and Costco Earnings: What to Watch This Week (The Wall Street Journal)
Dec-08-25 07:00PM	GameStop earnings, JOLTS labor data: What to Watch (Yahoo Finance Video)
04:54PM	Earnings live: Toll Brothers stock falls on margin softness; investors look to Oracle, Broadcom results ahead (Yahoo Finance)
11:19AM	Market Eagerly Awaits FOMC Policy Decision (Zacks)
10:36AM	Pre-markets Up for Nasdaq and Russell 2000, Flat for Dow (Zacks)
06:10AM	Stocks Set to Open Higher as Investors Await Fed Meeting (Barchart)
03:45AM	Fed Rate Decision, Broadcom and Costco Earnings: What to Watch This Week (The Wall Street Journal)
Dec-07-25 10:02PM	AutoZone (AZO) Q4 Earnings: What To Expect (StockStory)
02:00PM	Fed Rate Decision, Adobe, Oracle, Costco, Broadcom, and More Stocks to Watch This Week (Barrons.com)
07:45AM	Crucial Fed decision looms as stocks fly high near records: What to watch this week (Yahoo Finance)
05:00AM	What to Expect in Markets This Week: Fed Interest Rate Decision and Powell Remarks; Earnings From Oracle, Broadcom (Investopedia)
Dec-05-25 04:15PM	Earnings live: Mentions of 'AI' on earnings calls reach peak levels as Oracle gears up to report (Yahoo Finance)
04:08PM	Fed Meeting, Broadcom Earnings: What to Watch Next Week (The Wall Street Journal)
Dec-04-25 01:00PM	The Week Ahead: Rate Cut Decision, Broadcom Earnings (Schaeffer's Research)
09:15AM	Seeking Clues to AutoZone (AZO) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics (Zacks)
09:08AM	Here Are Thursdays Top Wall Street Analyst Research Calls: AutoZone, BXP, Fiserv, Meta Platforms, PayPal, Salesforce, Toast and More (24/7 Wall St.)
Dec-03-25 04:23AM	Is AutoZone Stock Underperforming the Nasdaq? (Barchart)
Dec-02-25 05:50PM	AutoZone (AZO) Stock Slides as Market Rises: Facts to Know Before You Trade (Zacks)
01:55PM	Why AutoZone (AZO) Shares Are Sliding Today (StockStory)
10:00AM	AutoZone (AZO) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release (Zacks)
Dec-01-25 02:58AM	Analysts Are Bullish On AutoZone (AZO)'s Shares (Insider Monkey)
Nov-27-25 09:00AM	AutoZone, Inc. (AZO) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Nov-26-25 01:11PM	Black Friday doesn't guarantee lower prices, as tariffs have led some stores to raise them (MarketWatch)
Nov-25-25 09:13AM	Are Wall Street Analysts Bullish on AutoZone Stock? (Barchart)
Nov-21-25 05:00PM	AutoZone to hold Stockholders' Meeting December 17, 2025 (GlobeNewswire)
Nov-20-25 09:30AM	Brokers Suggest Investing in AutoZone (AZO): Read This Before Placing a Bet (Zacks)
Nov-19-25 05:00PM	AutoZone to Release First Quarter Fiscal 2026 Earnings December 9, 2025 (GlobeNewswire)
Nov-16-25 11:46PM	1 of Wall Street's Favorite Stock to Target This Week and 2 We Avoid (StockStory)
Nov-14-25 09:00AM	Investors Heavily Search AutoZone, Inc. (AZO): Here is What You Need to Know (Zacks)
08:30AM	Jim Cramer Wants You to Buy These 2 Incredibly Inexpensive Stocks (24/7 Wall St.)
Nov-13-25 10:45AM	Goldman Sachs upgrades AutoZone to Buy, lifts Genuine Parts to Neutral (Investing.com)
09:45AM	Nike upgraded, Dollar Tree downgraded: Wall Street's top analyst calls (The Fly)
09:10AM	Here Are Thursdays Top Wall Street Analyst Research Calls: AbbVie, AppLovin, Autozone, Booking Holdings, CoreWeave, DoorDash, and More (24/7 Wall St.)
Nov-10-25 04:28AM	Q3 Rundown: AutoZone (NYSE:AZO) Vs Other Auto Parts Retailer Stocks (StockStory)
Nov-08-25 01:01PM	Tariffs Are Hurting DIY Car Mechanics, O'Reilly Auto Parts, AutoZone CEOs Say (Benzinga)
Nov-05-25 01:54PM	Lawsuit says First Brands founder splurged on exotic cars and celebrity chefs before bankruptcy (Associated Press Finance)
Nov-04-25 05:50PM	AutoZone (AZO) Ascends While Market Falls: Some Facts to Note (Zacks)
09:30AM	Wall Street Bulls Look Optimistic About AutoZone (AZO): Should You Buy? (Zacks)
06:23AM	1 Consumer Stock for Long-Term Investors and 2 That Underwhelm (StockStory)
Nov-03-25 01:45PM	Analyst Report: AutoZone, Inc. (Morningstar Research)
Oct-29-25 05:50PM	AutoZone (AZO) Stock Moves -2.47%: What You Should Know (Zacks)
12:34AM	1 Profitable Stock with Impressive Fundamentals and 2 We Turn Down (StockStory)
Oct-28-25 09:26AM	What to Expect From AutoZone's Q1 2026 Earnings Report (Barchart)
Oct-27-25 04:20PM	Is AutoZone (AZO) The Best Auto Stock to Buy? (Insider Monkey)
Oct-25-25 10:37AM	O'Reilly Auto Parts CEO warns consumers will see change in stores (TheStreet)
10:37AM	O'Reilly Auto Parts CEO sounds alarm on shift in customer behavior (TheStreet)
Oct-24-25 07:21PM	Analyst Report: AutoZone, Inc. (Morningstar Research)
Oct-23-25 05:23PM	O'Reilly Automotive's Stock Price Uptrend Will Continue in 2026 (MarketBeat)
11:30AM	Why Is AutoZone (AZO) Down 4.3% Since Last Earnings Report? (Zacks)
Oct-22-25 09:00AM	Is Trending Stock AutoZone, Inc. (AZO) a Buy Now? (Zacks)
Oct-21-25 06:00AM	Hiltzik: The sudden financial collapse of this big auto parts firm points to the next market meltdown (LA Times)
Oct-20-25 05:50PM	AutoZone (AZO) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)

AutoZone, Inc. engages in the retail and distribution of automotive replacement parts and accessories. It operates under the Auto Part Stores and Other segments. The company was founded by Joseph R. Hyde, III in 1979 and is headquartered in Memphis, TN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
JACKSON JAMERE	CFO	Dec 10 '25	Buy	3413.50	55	187,742	488	Dec 12 05:56 PM
Borninkhof K. Michelle	Senior Vice President & CIO	Oct 27 '25	Option Exercise	1519.62	300	455,886	716	Oct 29 05:35 PM
Borninkhof K. Michelle	Senior Vice President & CIO	Oct 27 '25	Sale	3775.00	300	1,132,500	416	Oct 29 05:35 PM
Borninkhof K. Michelle	Officer	Oct 27 '25	Proposed Sale	3775.00	300	1,132,500		Oct 27 10:29 AM
Daniele Philip B.	President & CEO	Oct 17 '25	Option Exercise	587.13	2,533	1,487,200	2,588	Oct 20 05:10 PM
Daniele Philip B.	President & CEO	Oct 17 '25	Sale	4020.88	2,533	10,184,893	55	Oct 20 05:10 PM
Daniele Philip B.	Officer	Oct 17 '25	Proposed Sale	4020.88	2,533	10,184,895		Oct 17 04:00 PM
Daniele Philip B.	President & CEO	Oct 09 '25	Option Exercise	587.13	500	293,565	701	Oct 14 05:27 PM
Murphy John Scott	Vice President, Controller	Sep 24 '25	Option Exercise	653.31	2,860	1,868,456	4,104	Sep 26 04:50 PM
Murphy John Scott	Vice President, Controller	Sep 24 '25	Sale	4175.70	2,860	11,942,494	1,244	Sep 26 04:50 PM
Murphy John Scott	Officer	Sep 24 '25	Proposed Sale	4175.70	2,860	11,942,490		Sep 24 04:28 PM
Smith Richard Craig	Sr. Vice President	Jul 24 '25	Option Exercise	744.85	3,000	2,234,550	5,925	Jul 25 05:02 PM
Smith Richard Craig	Sr. Vice President	Jul 24 '25	Sale	3875.90	3,000	11,627,700	2,925	Jul 25 05:02 PM
Smith Richard Craig	Officer	Jul 24 '25	Proposed Sale	3875.90	3,000	11,627,700		Jul 24 02:02 PM
Borninkhof K. Michelle	Senior Vice President & CIO	Jun 20 '25	Option Exercise	1519.62	750	1,139,715	1,156	Jun 23 04:56 PM
Borninkhof K. Michelle	Senior Vice President & CIO	Jun 20 '25	Sale	3597.13	750	2,697,850	406	Jun 23 04:56 PM
Borninkhof K. Michelle	Officer	Jun 20 '25	Proposed Sale	3597.13	750	2,697,850		Jun 20 10:10 AM
RHODES WILLIAM C III	Executive Chairman	Jun 10 '25	Option Exercise	1060.81	27,500	29,172,275	39,539	Jun 12 04:55 PM
RHODES WILLIAM C III	Executive Chairman	Jun 10 '25	Sale	3708.93	27,500	101,995,724	8,546	Jun 12 04:55 PM
RHODES WILLIAM C III	Director	Jun 10 '25	Proposed Sale	3700.00	27,500	101,750,000		Jun 10 05:28 PM
RHODES WILLIAM C III	Director	Jun 10 '25	Proposed Sale	3700.00	2,500	9,250,000		Jun 10 03:53 PM
RHODES WILLIAM C III	Director	Jun 10 '25	Proposed Sale	3464.75	1	3,465		Jun 10 12:48 PM
JACKSON JAMERE	CFO	May 30 '25	Option Exercise	1128.95	2,962	3,343,950	3,039	Jun 02 04:23 PM
JACKSON JAMERE	CFO	May 30 '25	Sale	3728.05	2,612	9,737,671	427	Jun 02 04:23 PM
JACKSON JAMERE	Officer	May 30 '25	Proposed Sale	3728.05	2,612	9,737,674		May 30 11:35 AM
HURTADO DOMINGO	Sr. Vice President	Apr 22 '25	Option Exercise	1139.99	4,800	5,471,952	4,959	Apr 23 05:42 PM
HURTADO DOMINGO	Sr. Vice President	Apr 22 '25	Sale	3660.00	4,800	17,568,000	159	Apr 23 05:42 PM
HURTADO DOMINGO	Officer	Apr 22 '25	Proposed Sale	3660.00	4,800	17,568,000		Apr 22 03:56 PM
GOULD ERIC S.	Sr. Vice President	Mar 31 '25	Option Exercise	744.85	1,500	1,117,275	2,405	Apr 02 04:18 PM
GOULD ERIC S.	Sr. Vice President	Mar 31 '25	Sale	3800.00	1,500	5,700,000	905	Apr 02 04:18 PM
GOULD ERIC S.	Officer	Mar 31 '25	Proposed Sale	3800.00	1,500	5,700,000		Mar 31 09:59 AM
Daniele Philip B.	President & CEO	Mar 27 '25	Option Exercise	744.85	2,000	1,489,700	2,163	Mar 28 05:11 PM
Daniele Philip B.	President & CEO	Mar 27 '25	Sale	3800.01	2,000	7,600,020	163	Mar 28 05:11 PM
Daniele Philip B.	Officer	Mar 27 '25	Proposed Sale	3800.01	2,000	7,600,018		Mar 27 12:22 PM
Smith Richard Craig	Sr. Vice President	Mar 20 '25	Option Exercise	750.77	2,850	2,139,681	5,774	Mar 21 05:35 PM
Smith Richard Craig	Sr. Vice President	Mar 20 '25	Sale	3610.00	2,850	10,288,500	2,924	Mar 21 05:35 PM
Smith Richard Craig	Officer	Mar 20 '25	Proposed Sale	3610.00	2,850	10,288,500		Mar 20 12:52 PM
Borninkhof K. Michelle	Senior Vice President & CIO	Mar 11 '25	Sale	3550.08	136	481,575	403	Mar 13 05:12 PM
LeRiche Dennis W.	Sr. Vice President	Mar 07 '25	Option Exercise	587.13	1,575	924,730	1,992	Mar 11 05:07 PM
LeRiche Dennis W.	Sr. Vice President	Mar 07 '25	Sale	3600.00	1,575	5,670,000	417	Mar 11 05:07 PM
Borninkhof K. Michelle	Officer	Mar 11 '25	Proposed Sale	3541.00	136	481,575		Mar 11 01:23 PM
CHILDRESS BAILEY L.	SVP, Merchandising Support	Mar 05 '25	Option Exercise	1139.99	160	182,398	210	Mar 07 05:08 PM
CHILDRESS BAILEY L.	SVP, Merchandising Support	Mar 05 '25	Sale	3550.00	160	568,000	50	Mar 07 05:08 PM
LeRiche Dennis W.	Officer	Mar 07 '25	Proposed Sale	3600.00	1,575	5,670,000		Mar 07 01:52 PM
CHILDRESS BAILEY L.	Officer	Mar 05 '25	Proposed Sale	3550.00	160	568,000		Mar 05 03:10 PM
MRKONIC GEORGE R JR	Director	Jan 02 '25	Proposed Sale	3212.83	337	1,082,725		Jan 02 11:45 AM
JORDAN D BRYAN	Director	Dec 20 '24	Proposed Sale	3216.52	2,858	9,192,826		Dec 20 11:45 AM

Open in Screener

LLY

Lilly(Eli) & Co

Dec 12 • 04:00PM ET

1,027.51

+18.13 1.80 %

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: NVO JNJ ABBV MRK AZN AMGN PFE SNY BMY GSK

| Held by: VTI VOO SPY IVV VUG XLV VIG IWF VHT IVW

Index	S&P 500	P/E	50.82	EPS (ttm)	20.22	Insider Own	9.96%	Shs Outstand	945.84M	Perf Week	1.70%
Market Cap	971.39B	Forward P/E	31.76	EPS next Y	32.35	Insider Trans	-3.90%	Shs Float	851.21M	Perf Month	0.96%
Enterprise Value	1004.04B	PEG	0.70	EPS next Q	7.17	Inst Own	73.21%	Short Float	0.83%	Perf Quarter	37.33%
Income	18.41B	P/S	16.35	EPS this Y	83.40%	Inst Trans	-1.01%	Short Ratio	1.86	Perf Half Y	25.40%
Sales	59.42B	P/B	40.85	EPS next Y	35.81%	ROA	19.33%	Short Interest	7.07M	Perf YTD	33.10%
Book/sh	25.16	P/C	97.99	EPS next 5Y	45.16%	ROE	96.82%	52W High	1111.99 -7.60%	Perf Year	28.51%
Cash/sh	10.49	P/FCF	104.77	EPS past 3/5Y	24.14% 18.77%	ROIC	28.47%	52W Low	623.78 64.72%	Perf 3Y	176.23%
Dividend Est.	5.91 (0.57%)	EV/EBITDA	35.50	Sales past 3/5Y	16.73% 15.08%	Gross Margin	83.03%	Volatility	3.12% 2.73%	Perf 5Y	596.99%
Dividend TTM	6.00 (0.58%)	EV/Sales	16.90	EPS Y/Y TTM	120.94%	Oper. Margin	44.41%	ATR (14)	29.11	Perf 10Y	1086.23%
Dividend Ex-Date	Feb 13, 2026	Quick Ratio	1.24	Sales Y/Y TTM	45.41%	Profit Margin	30.99%	RSI (14)	57.78	Recom	1.65
Dividend Gr. 3/5Y	15.21% 15.05%	Current Ratio	1.55	EPS Q/Q	479.29%	SMA20	-1.02%	Beta	0.35	Target Price	1146.08
Payout	44.39%	Debt/Eq	1.79	Sales Q/Q	53.87%	SMA50	9.95%	Rel Volume	0.85	Prev Close	1009.38
Employees	47000	LT Debt/Eq	1.72	Earnings	Oct 30 BMO	SMA200	26.14%	Avg Volume	3.81M	Price	1027.51
IPO	Jul 09, 1970	Option/Short	Yes / Yes	EPS/Sales Surpr.	23.33% 9.64%	Trades		Volume	3,242,224	Change	1.80%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-13-25	Initiated	Scotiabank	Sector Outperform	$1165
Nov-10-25	Upgrade	Leerink Partners	Market Perform → Outperform	$1104
Oct-20-25	Reiterated	BMO Capital Markets	Outperform	$840 → $930
Oct-14-25	Upgrade	Erste Group	Hold → Buy
Sep-17-25	Downgrade	Berenberg	Buy → Hold	$830
Aug-27-25	Upgrade	HSBC Securities	Reduce → Hold	$700
Aug-18-25	Downgrade	Daiwa Securities	Outperform → Neutral	$700
Aug-07-25	Downgrade	Leerink Partners	Outperform → Market Perform	$715
Jun-05-25	Downgrade	Erste Group	Buy → Hold
Apr-28-25	Downgrade	HSBC Securities	Buy → Reduce	$1150 → $700
Apr-22-25	Initiated	Cantor Fitzgerald	Overweight	$975
Dec-10-24	Resumed	BofA Securities	Buy	$997
Nov-15-24	Initiated	Wolfe Research	Outperform	$1000
Oct-17-24	Initiated	Bernstein	Outperform	$1100
Sep-13-24	Resumed	Citigroup	Buy	$1060
Aug-12-24	Upgrade	Deutsche Bank	Hold → Buy	$1025
Feb-21-24	Downgrade	DZ Bank	Buy → Hold	$820
Feb-16-24	Reiterated	Morgan Stanley	Overweight	$805 → $950
Dec-21-23	Downgrade	Daiwa Securities	Buy → Outperform	$660 → $610
Nov-09-23	Initiated	Deutsche Bank	Hold	$535

Show Previous Ratings

Dec-13-25 02:57PM	My Top 3 Healthcare Stocks to Buy in 2026 (Motley Fool)
08:04AM	Eli Lilly Leads Five Stocks Near Buy Points In Divided Market (Investor's Business Daily)
07:44AM	Stock Market Week Ahead: A Catch-Up Week For Econ Data (Investor's Business Daily)
04:30AM	My Top 10 Stocks to Buy for 2026 (Motley Fool)
Dec-12-25 05:45PM	Why the Market Dipped But Eli Lilly (LLY) Gained Today (Zacks)
04:04PM	Loading…
04:04PM	Eli Lilly Rises, Again, After EMA Groups Recommends Mounjaro For Children As Young As 10 (Investor's Business Daily)
02:07PM	Fed Rate Cut, Big Tech Slide Highlight Volatile Week (Schaeffer's Research)
01:52PM	Novo's Next Shot at Dominance: High-Dose Wegovy Takes Aim at Lilly's Zepbound (GuruFocus.com)
11:45AM	Updated data for Lilly's Inluriyo (imlunestrant) reinforce efficacy results as monotherapy and in combination with Verzenio (abemaciclib) in ER+, HER2- advanced breast cancer (PR Newswire)
11:17AM	Eli Lilly's Next-Generation Obesity Drug Secures First Phase III Win (Zacks)
11:10AM	Eli Lilly Rises, Again, After EMA Recommends Mounjaro For Children As Young As 10 (Investor's Business Daily)
10:37AM	NVO Down 42% Year to Date: Is This an Indication to Sell the Stock? (Zacks)
10:20AM	Dow Jones, Russell 2000 Hit Highs, Buoyed By Fed; Oracle, Broadcom Weigh On Techs: Weekly Review (Investor's Business Daily)
09:55AM	Rival Healthcare Proposals Fail in Senate (The Wall Street Journal)
09:00AM	Ozempic launches in India at $24 a week as Novo targets booming market (Reuters Videos)
08:18AM	Loading…
08:18AM	Novo Nordisk Stumbles as Obesity Drug Race Heats Up (GuruFocus.com)
07:42AM	AbbVie Slipped Below 50-Day SMA Last Week: How to Play the Stock (Zacks)
07:29AM	Lillys triple G agonist boasts 28.7% weight loss in Phase III trial (Clinical Trials Arena)
07:02AM	Think Eli Lilly Is Expensive? This Metric Says Otherwise. (Motley Fool)
05:30AM	Why a Budding Drug-Price Revolution Isn't Quite What it Seems (The Wall Street Journal)
12:01AM	Oh no, Ozempic! Eli Lillys New Weight-Loss Drug KOs Rival Treatments (The Daily Upside)
Dec-11-25 08:14PM	Why Novo Nordisk Stock Topped the Market on Thursday (Motley Fool)
05:38PM	Dow Jones, Russell 2000 Hit Highs; Broadcom Sees AI Chip Sales Doubling (Investor's Business Daily)
04:28PM	Eli Lilly Puts Obesity Field 'On Notice' With Best-Ever Weight Loss (Investor's Business Daily)
04:23PM	How major US stock indexes fared Thursday, 12/11/2025 (Associated Press)
02:00PM	Stocks to Watch Thursday: Disney, Eli Lilly, Coca-Cola, Rivian (The Wall Street Journal)
12:19PM	Eli Lilly Stock Rises After New Obesity Drug Crushes Phase 3 Goals (GuruFocus.com)
12:11PM	Missed Ozempic? Lilly's Next Drug Could Be Even Bigger (GuruFocus.com)
12:06PM	3 Dividend ETFs to Buy and Hold for Life if the Market Crashes (24/7 Wall St.)
12:00PM	Eli Lilly (LLY) Stock Is Up, What You Need To Know (StockStory)
11:23AM	Loading…
11:23AM	Eli Lilly's Latest Obesity Drug Delivers Strong Results. It Might Work Too Well. (Barrons.com)
11:16AM	2 Pharma Stocks Pop on Strong Obesity Drug Trial Results (Schaeffer's Research)
10:37AM	Eight stock picks to play one of the healthiest corners of the market (MarketWatch)
10:30AM	Roche's Breast Cancer Drug Cuts Risk of Death by 30% in Phase III (Zacks)
10:23AM	Can Eli Lilly Sustain Its Obesity Momentum as Newer Players Emerge? (Zacks)
10:15AM	WVE Stock Surges More Than 180% in a Week: What Is Driving This Rally? (Zacks)
09:35AM	New Lilly Shot Reduces Body Weight by 23% in Study (Bloomberg)
09:32AM	Eli Lilly's obesity drug trial results, Coca-Cola names next CEO (Yahoo Finance Video)
09:30AM	Eli Lilly Reports Dramatic Weight Loss in Next-Gen Obesity-Drug Trial (The Wall Street Journal)
09:26AM	Eli Lilly Reports Strong Late-Stage Results for Next-Generation Obesity Drug Retatrutide (GuruFocus.com)
09:12AM	GSK Stock Up Almost 19% in 3 Months: Should You Buy, Hold or Sell? (Zacks)
08:33AM	Lilly Reports Positive Results in Next-Gen Obesity Drug Trial (The Wall Street Journal)
07:55AM	Eli Lilly's newest weight-loss drug relieved pain in patients with knee osteoarthritis (MarketWatch)
07:54AM	Eli Lilly Reports Positive Results From Study of Weight Loss Drug (The Wall Street Journal)
07:28AM	Eli Lilly stock climbs after retatrutide delivers massive weight loss in trial (Investing.com)
07:13AM	Eli Lilly's Experimental Obesity Drug Cut Weight By 23.7% (Investor's Business Daily)
06:45AM	Lilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial (PR Newswire)
02:52AM	Eli Lilly's Mounjaro Added to China's National Health Insurance for Diabetes (Insider Monkey)
02:00AM	Microsoft, Broadcom, Lilly, and Other Stocks That Meet This Pros Definition of Quality (Barrons.com)
01:15AM	Novo Nordisk Is Trading as If Obesity Drug Craze Never Happened (Bloomberg)
Dec-10-25 05:27PM	Golden Cross Alert: 3 Stocks With Major Upside Potential (MarketBeat)
04:35PM	Warning: This Skyrocketing Stock Has a Hidden Risk (Motley Fool)
04:15PM	Hims stock falls after lawmakers propose GLP-1 compounding restrictions (Investing.com)
04:08PM	The Top 3 Investment Themes That Will Dominate 2026 (MarketBeat)
04:02PM	Eli Lilly's Weight-Loss Drugs Drove Its Stock Higher This Year. A New Plant in Alabama Could Boost Production (Investopedia)
11:28AM	Eli Lilly and Company (LLY) Announces Results From Phase 3 BRUIN CLL-314 Trial Evaluating Jaypirca Versus Imbruvica (Insider Monkey)
10:53AM	Eli Lilly Plans $6B Investment in New Alabama Manufacturing Site (GuruFocus.com)
10:20AM	2 Pharmaceutical Stocks to Buy at a Discount (Motley Fool)
10:17AM	Can NVO Defend Its Obesity Lead as GLP-1 Competition Intensifies? (Zacks)
07:43AM	PFE Buys Oral GLP-1 Drug From China Biotech to Boost Obesity Presence (Zacks)
06:26AM	Eli Lilly to Invest $6 Billion in New Alabama Manufacturing Plant (GuruFocus.com)
06:20AM	Eli Lilly picks Alabama as home to $6bn orforglipron manufacturing facility (Pharmaceutical Technology)
04:30AM	China's Fosun Pharma unit strikes US$2.1 billion obesity drug deal with Pfizer (South China Morning Post)
Dec-09-25 04:13PM	In The 'Uber Bull' Biotech Market, Is Structure The Next Metsera? (Investor's Business Daily)
03:59PM	Eli Lilly to Build $6 Billion Alabama Plant as Part of U.S. Investment (The Wall Street Journal)
03:30PM	Lilly to build $6 billion facility to manufacture active pharmaceutical ingredients in Alabama (PR Newswire)
01:40PM	Pharma ETFs to Gain From Landmark UK-US Zero-Tariff Deal (Zacks)
01:35PM	Prediction: This Surprising Growth Stock Will Reach -- and Stay in -- the Trillion-Dollar Club in 2026. (Motley Fool)
12:30PM	Pfizer Expands Obesity Pipeline With Up to $2.1 Billion Deal for YaoPharma Pill (GuruFocus.com)
11:50AM	Pfizer Turns to China for Trial Weight Loss Drug. Congress Is Worried About Chinese Biotechs. (Barrons.com)
11:19AM	Cramer Loves These Dividend Stocks (24/7 Wall St.)
11:15AM	1 Major Factor Behind the Healthcare Sector's Recent Surge (Motley Fool)
09:27AM	GPCR Stock Soars 102% on Strong Phase II Obesity Data for Aleniglipron (Zacks)
09:00AM	Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
08:28AM	Lilly and Adverum announce expiration and completion of Adverum tender offer and acquisition (PR Newswire)
07:30AM	Lilly's Jaypirca (pirtobrutinib) significantly improved progression-free survival, reducing the risk of progression or death by 80%, versus chemoimmunotherapy in patients with treatment-naive CLL/SLL (PR Newswire)
03:00AM	How Lilly uses Big Pharma heft to lift up-and-coming biotechs (Pharma Voice)
12:37AM	2 Potential Stock Splits to Watch for in 2026 (Motley Fool)
Dec-08-25 07:55PM	Review Preview: Fed Jitters (Barrons.com)
04:10PM	Structure Therapeutics Soars; CEO Says It Could Have 'Best In Class' Weight-Loss Drug (Investor's Business Daily)
04:07PM	Kymera Rockets, Pulling Nurix Higher. Does It Have The Next Dupixent? (Investor's Business Daily)
02:05PM	Lilly declares first-quarter 2026 dividend (PR Newswire)
01:53PM	Will Cobenfy Become a Growth Driver for BMY's Neuroscience Business? (Zacks)
01:23PM	Retail investors were net buyers of stocks in November, according to Schwab data (MarketWatch)
12:46PM	Obesity Biotechs' Gains Hit Shares of Eli Lilly, Novo Nordisk (Barrons.com)
12:36PM	Guggenheim Maintains Buy on Eli Lilly (LLY) After "Another Impressive Year" (Insider Monkey)
12:00PM	Drugmakers Are Ditching Middlemen to Sell Directly to Patients (The Wall Street Journal)
10:53AM	Top-Ranked ETFs to Power Your Portfolio Higher (Zacks)
10:36AM	Structure Therapeutics Stock Jumps on Trial Results for Weight-Loss Pill (The Wall Street Journal)
10:00AM	Carolyn Bertozzi returns to Lilly board of directors (PR Newswire)
09:45AM	Why Eli Lilly (LLY) is a Top Growth Stock for the Long-Term (Zacks)
09:21AM	Lillys GLP-1 Surge Dwarfs Abbotts Steady Device Growth With 54% Revenue Jump (24/7 Wall St.)
09:12AM	Structure details positive trial data for a weight-loss pill, and the stock rockets (MarketWatch)
12:32AM	Jim Cramer Prefers Buying Eli Lilly When People Are "Getting Antsy" (Insider Monkey)
Dec-07-25 04:30PM	Lilly's Jaypirca (pirtobrutinib) met its primary endpoint in first-of-its-kind, head-to-head Phase 3 study versus Imbruvica (ibrutinib) (PR Newswire)
09:42AM	At ASH, Lilly makes case to widen Jaypirca use in leukemia, lymphoma (BioPharma Dive)
Dec-06-25 05:27PM	Eli Lilly's Stock Drops as It Slashes the Price of Zepbound: Time to Buy the Dip? (Motley Fool)
Dec-05-25 04:25PM	Do These 3 Healthcare Stocks Need a Checkup? (Motley Fool)
02:41PM	Tech Rebound, Economic Data Fuels Weekly Gains (Schaeffer's Research)
02:41PM	Tech Rebound, Economic Data Fuel Weekly Gains (Schaeffer's Research)

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
LILLY ENDOWMENT INC	10% Owner	Nov 25 '25	Sale	1109.30	15,632	17,340,625	92,196,978	Nov 26 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 25 '25	Sale	1095.35	147,061	161,082,640	92,212,610	Nov 26 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 24 '25	Sale	1068.52	142,307	152,058,091	92,359,671	Nov 25 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 21 '25	Sale	1058.66	105,326	111,504,098	92,501,978	Nov 24 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 24 '25	Proposed Sale	1059.70	305,000	323,208,500		Nov 24 03:01 PM
LILLY ENDOWMENT INC	10% Owner	Nov 20 '25	Sale	1051.66	37,148	39,067,117	92,607,304	Nov 21 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 19 '25	Sale	1051.17	167,526	176,098,702	92,644,452	Nov 20 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 18 '25	Sale	1034.78	60,213	62,306,969	92,811,978	Nov 19 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 19 '25	Proposed Sale	1030.05	310,000	319,315,500		Nov 19 03:05 PM
LILLY ENDOWMENT INC	10% Owner	Nov 17 '25	Sale	1030.68	9,886	10,189,269	92,872,191	Nov 18 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 14 '25	Sale	1030.87	178,295	183,799,044	92,882,077	Nov 17 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 13 '25	Sale	1030.26	46,606	48,016,098	93,060,372	Nov 14 04:00 PM
Zakrowski Donald A	SVP, Finance, & CAO	Nov 13 '25	Sale	1010.50	1,000	1,010,500	2,840	Nov 13 04:14 PM
LILLY ENDOWMENT INC	10% Owner	Nov 12 '25	Sale	1011.18	305,000	308,411,204	93,106,978	Nov 13 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 13 '25	Proposed Sale	1017.78	295,000	300,245,100		Nov 13 03:02 PM
LILLY ENDOWMENT INC	10% Owner	Nov 11 '25	Sale	986.64	283,131	279,347,680	93,411,978	Nov 12 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 10 '25	Sale	972.52	16,869	16,405,396	93,695,109	Nov 12 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 12 '25	Proposed Sale	988.62	305,000	301,529,100		Nov 12 03:15 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 10 '25	Proposed Sale	924.37	300,000	277,311,000		Nov 10 03:11 PM
LILLY ENDOWMENT INC	10% Owner	Nov 05 '25	Sale	951.56	40,432	38,473,442	93,711,978	Nov 06 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 05 '25	Sale	933.26	179,042	167,092,104	93,752,410	Nov 06 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 04 '25	Sale	910.72	526	479,038	93,931,452	Nov 05 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 03 '25	Sale	888.83	300,000	266,648,921	93,931,978	Nov 04 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 04 '25	Proposed Sale	896.53	220,000	197,236,600		Nov 04 03:05 PM
LILLY ENDOWMENT INC	10% Owner	Oct 31 '25	Sale	863.35	301,342	260,165,031	94,231,978	Nov 03 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 03 '25	Proposed Sale	862.86	300,000	258,858,000		Nov 03 03:06 PM
LILLY ENDOWMENT INC	10% Owner	Oct 10 '25	Sale	863.24	3,658	3,157,722	94,533,320	Oct 14 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 09 '25	Sale	852.49	10,602	9,038,055	94,536,978	Oct 10 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 10 '25	Proposed Sale	855.35	305,000	260,881,750		Oct 10 02:57 PM
LILLY ENDOWMENT INC	10% Owner	Oct 08 '25	Sale	850.27	101,420	86,234,874	94,547,580	Oct 09 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 07 '25	Sale	848.01	26,795	22,722,401	94,649,000	Oct 08 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 06 '25	Sale	850.22	161,183	137,041,657	94,675,795	Oct 07 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 03 '25	Sale	837.93	192,404	161,220,401	94,836,978	Oct 06 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 06 '25	Proposed Sale	839.87	300,000	251,961,000		Oct 06 03:35 PM
LILLY ENDOWMENT INC	10% Owner	Oct 02 '25	Sale	821.55	112,596	92,503,361	95,029,382	Oct 03 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 01 '25	Sale	821.47	215,822	177,290,448	95,141,978	Oct 02 04:56 PM
LILLY ENDOWMENT INC	10% Owner	Oct 01 '25	Sale	794.15	135,193	107,363,016	95,357,800	Oct 02 04:55 PM
LILLY ENDOWMENT INC	10% Owner	Oct 02 '25	Proposed Sale	825.42	305,000	251,753,100		Oct 02 03:20 PM
LILLY ENDOWMENT INC	10% Owner	Oct 01 '25	Proposed Sale	763.00	295,000	225,085,000		Oct 01 04:08 PM
LILLY ENDOWMENT INC	10% Owner	Sep 30 '25	Sale	763.39	113,694	86,793,274	95,492,993	Oct 01 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Sep 19 '25	Sale	763.10	23,665	18,058,643	95,606,687	Sep 22 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Sep 18 '25	Sale	764.65	106,626	81,531,959	95,630,352	Sep 19 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Sep 18 '25	Proposed Sale	760.13	300,000	228,039,000		Sep 18 03:04 PM
DONALD ZAKROWSKI	Officer	Aug 28 '25	Proposed Sale	734.17	2,000	1,468,340		Aug 28 04:19 PM
Zakrowski Donald A	SVP, Finance, & CAO	Aug 28 '25	Sale	734.93	1,000	734,930	3,840	Aug 28 04:14 PM
Montarce Lucas	EVP & CFO	Aug 15 '25	Buy	691.79	715	494,627	14,685	Aug 15 04:13 PM
Alvarez Ralph	Director	Aug 13 '25	Buy	660.25	758	500,473	758	Aug 14 04:12 PM
Van Naarden Jacob	EVP & Pres., Lilly Oncology	Aug 13 '25	Buy	647.36	1,000	647,360	20,562	Aug 13 04:15 PM
Ricks David A	President, Chair, and CEO	Aug 12 '25	Buy	644.77	1,632	1,052,263	546,601	Aug 12 04:23 PM
Skovronsky Daniel	EVP, CSO & Pres. LRL & LLY Imm	Aug 12 '25	Buy	634.40	1,000	634,405	137,660	Aug 12 04:20 PM
Sulzberger Gabrielle	Director	Aug 12 '25	Buy	641.18	117	75,018	2,703	Aug 12 04:19 PM
Fyrwald J Erik	Director	Aug 12 '25	Buy	642.33	1,565	1,005,242	74,578	Aug 12 04:17 PM
Yuffa Ilya	EVP&Pres, LLY USA&Global Capab	Aug 11 '25	Sale	627.01	1,250	783,762	26,260	Aug 12 04:16 PM
JACKSON JAMERE	Director	Aug 08 '25	Buy	639.56	200	127,913	9,402	Aug 08 04:20 PM
Seymour Melissa	EVP, Global Quality	Aug 01 '25	Option Exercise	0.00	952	0	952	Aug 04 04:16 PM
LILLY ENDOWMENT INC	10% Owner	Jul 24 '25	Sale	805.07	280,000	225,419,259	95,736,978	Jul 25 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jul 24 '25	Proposed Sale	798.89	280,000	223,689,200		Jul 24 03:01 PM
Zakrowski Donald A	SVP, Finance, & CAO	May 27 '25	Sale	716.41	1,000	716,410	4,840	May 27 04:13 PM
Yuffa Ilya	EVP & President, LLY Int'l	May 14 '25	Sale	749.24	1,250	936,550	27,510	May 15 04:17 PM
Yuffa Ilya	Officer	May 14 '25	Proposed Sale	749.24	2,500	1,873,100		May 14 12:25 PM
DONALD ZAKROWSKI	Officer	Mar 13 '25	Proposed Sale	821.86	2,000	1,643,720		Mar 13 04:57 PM
Zakrowski Donald A	SVP, Finance, & CAO	Mar 13 '25	Sale	818.24	1,000	818,240	5,840	Mar 13 04:17 PM
LILLY ENDOWMENT INC	10% Owner	Mar 03 '25	Sale	928.76	220,000	204,326,151	96,016,978	Mar 04 04:00 PM
Dozier Eric	EVP, Chief People Officer	Mar 01 '25	Option Exercise	0.00	2,403	0	10,905	Mar 03 04:53 PM
Hernandez Edgardo	EVP & Pres., Mfg. Operations	Mar 01 '25	Option Exercise	0.00	2,837	0	41,009	Mar 03 04:51 PM
LILLY ENDOWMENT INC	10% Owner	Mar 03 '25	Proposed Sale	920.63	220,000	202,538,600		Mar 03 03:34 PM
LILLY ENDOWMENT INC	10% Owner	Feb 25 '25	Sale	903.07	225,000	203,190,794	96,236,978	Feb 26 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 24 '25	Sale	883.97	60,432	53,419,955	96,461,978	Feb 25 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 25 '25	Proposed Sale	881.40	225,000	198,315,000		Feb 25 03:05 PM
LILLY ENDOWMENT INC	10% Owner	Feb 21 '25	Sale	882.70	99,452	87,786,505	96,522,410	Feb 24 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 20 '25	Sale	877.99	14,685	12,893,353	96,621,862	Feb 21 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 19 '25	Sale	878.45	9,985	8,771,285	96,636,547	Feb 20 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 13 '25	Sale	879.52	35,446	31,175,396	96,646,532	Feb 14 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 13 '25	Proposed Sale	872.97	220,000	192,053,400		Feb 13 03:43 PM
Skovronsky Daniel	EVP, CSO & Pres. LRL & LLY Imm	Feb 10 '25	Sale	863.21	5,000	4,316,065	117,888	Feb 12 04:15 PM
Skovronsky Daniel	Officer	Feb 10 '25	Proposed Sale	863.19	5,000	4,315,954		Feb 10 11:44 AM
LILLY ENDOWMENT INC	10% Owner	Feb 06 '25	Sale	874.13	210,000	183,567,262	96,681,978	Feb 07 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 06 '25	Proposed Sale	842.18	210,000	176,857,800		Feb 06 04:04 PM
Yuffa Ilya	EVP & President, LLY Int'l	Feb 01 '25	Option Exercise	0.00	3,269	0	23,071	Feb 04 04:28 PM
White Anne E.	EVP & Pres, Lilly Neuroscience	Feb 01 '25	Option Exercise	0.00	3,269	0	68,838	Feb 04 04:27 PM
Van Naarden Jacob	EVP & Pres., Lilly Oncology	Feb 01 '25	Option Exercise	0.00	3,023	0	14,868	Feb 04 04:26 PM
Skovronsky Daniel	EVP, CSO & Pres. LRL & LLY Imm	Feb 01 '25	Option Exercise	0.00	8,989	0	126,892	Feb 04 04:25 PM
Ricks David A	President, Chair, and CEO	Feb 01 '25	Option Exercise	0.00	26,561	0	496,385	Feb 04 04:24 PM
Rau Diogo	EVP & CIDO	Feb 01 '25	Option Exercise	0.00	3,269	0	14,370	Feb 04 04:23 PM
Jonsson Patrik	EVP&Pres, CardMetHlth, LLY USA	Feb 01 '25	Option Exercise	0.00	3,433	0	48,016	Feb 04 04:23 PM
Hernandez Edgardo	EVP & Pres., Mfg. Operations	Feb 01 '25	Option Exercise	0.00	2,861	0	33,479	Feb 04 04:21 PM
Hakim Anat	EVP, GC & Secretary	Feb 01 '25	Option Exercise	0.00	4,904	0	20,683	Feb 04 04:19 PM

AZO

Autozone Inc

LLY

Lilly(Eli) & Co

Upgrade your FINVIZ experience